tiprankstipranks
Anebulo Pharmaceuticals (ANEB)
NASDAQ:ANEB
Holding ANEB?
Track your performance easily

Anebulo Pharmaceuticals (ANEB) Financial Statements

19 Followers

Anebulo Pharmaceuticals Financial Overview

Anebulo Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-0.306; its P/E ratio is -4.90; Anebulo Pharmaceuticals is scheduled to report earnings on February 7, 2025, and the estimated EPS forecast is $-0.08. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -2.20M$ -4.66M$ 1.59M$ -2.69M$ -2.54M
EBITDA$ -2.14M$ -4.60M$ 1.65M$ -2.69M$ -2.54M
Net Income Common Stockholders$ -2.20M$ -1.35M$ -1.65M$ -2.72M$ -2.48M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 1.40M$ 3.09M$ 5.15M$ 6.64M$ 8.52M
Total Assets$ 2.47M$ 4.07M$ 6.00M$ 7.50M$ 9.05M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -1.40M$ -3.09M$ -5.15M$ -6.64M$ -8.52M
Total Liabilities$ 569.23K$ 260.58K$ 1.01M$ 1.01M$ 716.56K
Stockholders Equity$ 1.90M$ 3.81M$ 4.99M$ 6.49M$ 8.33M
Cash Flow-
Free Cash Flow$ -1.69M$ -2.05M$ -1.50M$ -1.81M$ -2.73M
Operating Cash Flow$ -1.69M$ -2.05M$ -1.50M$ -1.81M$ -2.73M
Investing Cash Flow-----
Financing Cash Flow---$ -62.35K-
Currency in USD

Anebulo Pharmaceuticals Earnings and Revenue History

Anebulo Pharmaceuticals Debt to Assets

Anebulo Pharmaceuticals Cash Flow

Anebulo Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis